Memphis Internal Medicine — Memphis, Tennessee

Memphis Internal Medicine is a clinical research site located in Memphis, Tennessee, United States 38119.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Memphis Internal Medicine has participated in 2 clinical trials.

Therapeutic areas: Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease.

Sponsors: Cogentus Pharmaceuticals, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memphis Internal Medicine?

Memphis Internal Medicine has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memphis Internal Medicine conducted?

Memphis Internal Medicine has 2 clinical trials on record. Their work covers Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease.

Is Memphis Internal Medicine accredited by Crixeo Health?

Memphis Internal Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memphis Internal Medicine?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.